Companies - Akzo Nobel

Price

 
Price
€ 77,64
Change
€ 0,06
Change %
0,08%
Open
€ 77,30
High
€ 77,82
Low
€ 76,17
Volume
1.495.844

Profile

 
Profile
The history of AkzoNobel goes back to the year 1792, when the paint producing factory Sikkens was found. During the years, several mergers and acquisitions took place, which resulted in the company AKZO. Akzo became AkzoNobel after the merger with the Swedish chemical companz Nobel in 1994. The company has three main groups: pharmacy, coatings and chemicals. The products in the pharmacy division are, among others, anticonception, anti depressives, fertilization and animal vaccines. Pharmacy generates 25% of the total sales. AkzoNobel is the world leader in coatings, with the products of Flexa, Sikkens, International and Crown. Coatings make out 40% of the total sales. The chemical division produces salts and chemicals which are used in products like ice cream, toothpaste, cosmetics, glass and plastics. This is were the remaining sales comes from.
Industry
Chemicals
Description
Companies in the chemicals industry make raw materials, intermediate and final chemical end products, including gases, paints, plastics, fibers and resins. A distinction can be made between various bulk coarse (petro) chemicals and fine chemicals. The bulk chemicals like ethylene and propylene, are derived from petroleum and natural gas and form the raw material for plastics and other chemical products. Production takes place in large quantities and is very capital intensive. The margins are relatively small and the market has a cyclical character. The fine chemicals, including pigments, perfume and fragrances and raw materials for the pharmaceutical industry, are closer to the final product. The margins on these products are higher, but the production is more research-intensive. The market is in general less cyclical, but depend more on product introductions. The activities with the food, pharmaceutical and bio-related industries are indicated as life science activities. By focusing on integrated production and market leadership in a specific area, companies in the chemicals sector can build a competitive advantage.

Key figures (2016)

 
The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings
18,708
Price to Earnings (3 years)
21,820
Price to Earnings (5 years)
86,413
Price to earnings growth
0,613
Price/cashflow
11,514
Price/net cashflow
157,798
Price/book value
2,580
Price to sales
1,278

Ratios for dividend

Dividend yield
2,13%
Pay out
39,76%

Valuation ratios

Market value/PE
2,580
Market value/turnover
1,278
Enterprise value/turnover
1,162

Return ratios

Return on private equity
13,79%
Return on total equity
5,99%
Profit margin
6,83%

Risk ratios

Solvability
0,434
Solvability
1,768
Current ratio
1,390
Debt to Equity
1,303

Value invest ratios

Grahams Number
€ -14,14
Grahams Value
€ -91,78
Grahams Product
48,264
Grahams Product (3 years)
56,292

2016

 

Profit and loss

Net profit (x 1 mln)
€ 970,00
Turnover (x 1 mln)
€ 14.197,00
Cashflow(x 1 mln)
€ 1.576,00
Net cashflow(x 1 mln)
€ 115,00

Balance

Private equity (x 1 mln)
€ 7.034,00
Foreign equity (x 1 mln)
€ 9.162,00
Current assets (x 1 mln)
€ 5.857,00
Current liabilities (x 1 mln)
€ 4.213,00
Working capital (x 1 mln)
€ 1.644,00
Balance total (x 1 mln)
€ 16.196,00

Share

Outstanding shares (x 1 mln)
233,730
Price year-end
€ 59,39
Dividend per share
€ 1,65
Earnings per share
€ 4,15
Cashflow per share
€ 6,74
Net cashflow per share
€ 0,49
Book value per share
€ 30,09
Stockmarket value (x 1 mln)
€ 13.881,22

History

 
Year
2016
2015
2014
2013
2012
Net profit (x 1 mln)
€ 970,00
€ 979,00
€ 546,00
€ 724,00
€ -2.169,00
Turnover (x 1 mln)
€ 14.197,00
€ 14.859,00
€ 14.296,00
€ 14.590,00
€ 15.390,00
Price year-end
€ 59,39
€ 61,68
€ 57,65
€ 56,34
€ 49,75
Year high
€ 65,06
€ 75,45
€ 61,09
€ 56,49
€ 49,98
Year low
€ 49,91
€ 54,07
€ 46,59
€ 42,10
€ 34,85
Outstanding shares (x 1 mln)
233,730
247,800
246,000
242,600
239,000
Price to Earnings
14,311
15,612
25,974
18,879
-5,481
Earnings per share
€ 4,15
€ 3,95
€ 2,22
€ 2,98
€ -9,08
Dividends
€ 1,65
€ 1,55
€ 1,45
€ 1,45
€ 1,45
Dividend yield
2,78%
2,51%
2,52%
2,57%
2,91%
Pay out
39,76%
39,23%
65,33%
48,59%
-15,98%
Private equity (x 1 mln)
€ 7.034,00
€ 6.980,00
€ 6.267,00
€ 6.021,00
€ 7.357,00
PE per share
€ 30,09
€ 28,17
€ 25,48
€ 24,82
€ 30,78
Balance total (x 1 mln)
€ 16.196,00
€ 15.963,00
€ 16.299,00
€ 16.063,00
€ 17.963,00
Stockmarket value (x 1 mln)
€ 13.881,22
€ 15.284,30
€ 14.181,90
€ 13.668,08
€ 11.889,06

Company analysis

 

Analysis of profit indicators

Average profit per share (10 years)
€ 1,02
Standard deviation average profit
€ 4,05 (395,45%)
Average annual growth rate
-20,47%
Compound annual growth percentage
5,29%